Citadel Advisors LLC 13D and 13G filings for Decibel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 0 0.000% | -1,863,411 (Position Closed) | Filing |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 1,863,411 7.500% | 35,484 (+1.94%) | Filing |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 1,827,927 7.300% | 39,484 (+2.21%) | Filing |
| 2021-03-15 4:04 pm Purchase | 2021-03-05 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 1,396,871 5.100% | 1,396,871 (New Position) | Filing |
| 2021-03-01 4:01 pm Purchase | 2021-02-17 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 1,788,443 7.400% | 1,788,443 (New Position) | Filing |